PARK7 and seminoma: These levels likely reflect the levels of retained PARK7, suggesting that decreased levels of this protein in CS I seminoma patients may predict their poor prognosis, a suggestion in line with the assumption that RTI positivity correlates with the presence of occult (micro)metastases at diagnosis and with a significantly increased risk of disease recurrence.